Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma
Open Access
- 18 January 2023
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 4 (2) , 100915
Abstract
No abstract availableKeywords
Funding Information
- KWF Kankerbestrijding
- Oncode Institute
This publication has 57 references indexed in Scilit:
- BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITsJournal of Translational Medicine, 2012
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesotheliomaNature Genetics, 2011
- Frequent Mutation of BAP1 in Metastasizing Uveal MelanomasScience, 2010
- Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUBNature, 2010
- Role of the polycomb protein EED in the propagation of repressive histone marksNature, 2009
- Zoledronic acid induces formation of a pro‐apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF‐7 cells in vitroBritish Journal of Pharmacology, 2009
- Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic ratsProceedings of the National Academy of Sciences, 2008
- Polycomb silencers control cell fate, development and cancerNature Reviews Cancer, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005